TA

Thomas D. Aicher

LY Lycera: 5 patents #1 of 26Top 4%
Merck: 4 patents #99 of 1,208Top 9%
Overall (2017): #25,057 of 506,227Top 5%
5
Patents 2017

Issued Patents 2017

Patent #TitleCo-InventorsDate
9809561 Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease Chad A. VanHuis, William D. Thomas, John MacLean, Brian M. Andresen, Kenneth J. Barr +9 more 2017-11-07
9802958 Tetrahydro[1,8]naphthyridine sulfonamide and related compounds for use as agonists of RORy and the treatment of disease Peter L. Toogood, Xiao Hu 2017-10-31
9783511 Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of disease Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +6 more 2017-10-10
9663502 2-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of disease Chad A. VanHuis, John MacLean, Brian M. Andresen, Kenneth J. Barr, Corey E. Bienstock +9 more 2017-05-30
9657033 Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of disease Kenneth J. Barr, Blair T. Lapointe, Vladimir Simov, Karin Ann Stein, William D. Thomas +3 more 2017-05-23